Valeant Pharmaceuticals

Senior Statistician

Job ID
Pos. Category
Pos. Type
Full Time


Valeant Pharmaceuticals International, Inc. is a diverse and decentralized pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance. Our values provide the overall direction for our company, and provide us with the tools necessary to rise to any challenge by leveraging our collective hard work and effort along with our unwavering competitive spirit. These values help us set goals based on our organization’s potential and what we hope it will become.


Monitor product quality by performing statistical analysis of data to support marketed product and pre-market product formulations in accordance with SOPs and ISO and FDA regulations.




  • Provide appropriate statistical evaluation in order to assess:
    • data generated within the QLO stability program for shelf-life establishment, shelf-life extensions, and trend analysis
    • specification range setting
    • comparison between products and materials for change assessment
  • Assist in operational activities for the stability program. 
  • Train others in the appropriate application of stability tools.
  • Participate in the development of sampling plans, as requested.
  • Key relationships: Internal and external customers/sites


  • Bachelors Degree in Applied Statistics or similar technical discipline.
  • Minimum of 4 years of experience in positions performing statistical evaluations and analyses.
  • Previous experience with stability data preferred.
  • Lean Six Sigma training would be a plus.
  • Strong organizational skills and ability to multitask.
  • Strong verbal and written communication skills and ability to work effectively on teams

Be Aware of Recruiting Fraud

Valeant is an EEO/AA employer M/F/D/V.


Job Applicants should be aware of job offer scams perpetrated through the use of the Internet and social media platforms.


To learn more please read Valeant’s Job Offer Fraud Statement.


Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed